Male Health
Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031
The diabetic macular oedema (DMO) market is expected to grow at a compound annual growth rate (CAGR) of 6.0% over…
£40m GLP-1RA pilot scheme for obesity to begin in the UK
Earlier this month, plans were announced in the UK for a pilot programme to take measures on obesity. This £40m…
US FDA grants approval for Orion-Bayer’s Nubeqa combo for prostate cancer
The US Food and Drug Administration (FDA) has granted approval for a supplemental New Drug Application (sNDA) of Orion and its partner Bayer’s…
How close are we to getting a male contraceptive?
With advances in clinical studies evaluating male contraceptives, and laws restricting abortion access after Roe v. Wade was overturned in…
Approach to spur testosterone production instead of synthesis on the horizon
Low testosterone in men is a widespread clinical problem linked to obesity, high blood pressure and Type 2 diabetes. Nearly…
Concerns over safety on fertility are unfounded for Covid-19 vaccines
Achieving herd immunity to Covid-19 has been made difficult by internet disinformation campaigns. One such speculative idea is that Covid-19…
Breaking the taboo: disrupting the fertility sector
Infertility, defined by the World Health Organization as a disease of the reproductive system that results in disability, has long…
Black US men have higher risk of breast cancer than white men
Breast cancer is a malignant tumour that originates in the breast tissue. Most breast cancers are invasive tumours that have…
Reproductive Hormones and Protein Tests on the rise, says GlobalData
Reproductive hormones and protein tests are incredibly important for the pharmaceutical industry. They facilitate the control and regulations of many…
Prostate cancer incidence is increasing in younger populations
Prostate cancer is one of the most common malignancies occurring in men worldwide. Its diagnosis and screening techniques have been…
